טוען...
Evolving Treatment Paradigm in Metastatic Renal Cell Carcinoma
The treatment paradigm for advanced and metastatic renal cell carcinoma (mRCC) has evolved rapidly since the arrival of targeted therapies and novel immunotherapies. mRCC was previously treated only with cytokines. However, discoveries of mutations affecting the von Hippel-Lindau tumor suppressor ge...
שמור ב:
| הוצא לאור ב: | Am Soc Clin Oncol Educ Book |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6855178/ https://ncbi.nlm.nih.gov/pubmed/28561652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/EDBK_174469 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|